3-Isobutyl-pyrido<2,1-c>-s-triazol | 109730-29-2

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 三唑并吡啶类
• 英文名称: 3-Isobutyl-pyrido<2,1-c>-s-triazol
• 英文别名: 3-isobutyl-[1,2,4]triazolo[4,3-a]pyridine；3-(2-Methylpropyl)-[1,2,4]triazolo[4,3-a]pyridine
• CAS: 109730-29-2
• 化学式: C₁₀H₁₃N₃
• 分子量: 175.233
• InChiKey: YSOZHWDMAJXSQG-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.8
• 重原子数：
  13
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.4
• 拓扑面积：
  30.2
• 氢给体数：
  0
• 氢受体数：
  2

文献信息

• [EN] TETRAHYDROISOQUINOLINE COMPOUNDS AS NRF2 ACTIVATORS<br/>[FR] COMPOSÉS DE TÉTRAHYDROISOQUINOLÉINE UTILISÉS EN TANT QU'ACTIVATEURS DE NRF2
  申请人：C4X DISCOVERY LTD

  公开号：WO2021214472A1

  公开（公告）日：2021-10-28

  The present invention relates to compounds that are Nrf2 activators. The compounds have the structural formula I defined herein. The present invention also relates to processes for the preparation of these compounds, to pharmaceutical compositions comprising them, and to their use in the treatment of diseases or disorders associated with Nrf2 activation.

  本发明涉及一种Nrf2激活剂化合物。这些化合物具有本文中定义的结构式I。本发明还涉及制备这些化合物的方法，包括含有它们的药物组合物，以及它们在与Nrf2激活相关的疾病或紊乱治疗中的用途。
• THERAPEUTIC COMPOUNDS
  申请人：C4X Discovery Limited

  公开号：US20220002286A1

  公开（公告）日：2022-01-06

  The present invention relates to compounds that are Nrf2 activators. The compounds have the structural formula I defined herein. The present invention also relates to processes for the preparation of these compounds, to pharmaceutical compositions comprising them, and to their use in the treatment of diseases or disorders associated with Nrf2 activation.